Highlights From The 4th Global Precision Medicine & Biomarkers Leaders Summit
Posted 21st February 2018 by Jane Williams
With just 3 months to go until the Precision Medicine & Biomarkers Leaders Summit: USA, we have taken some time to reflect on the Euopean Precision Medicine & Biomarkers Leaders Summit that took place in Munich in September.
The Future of Personalised Medicine, Companion Diagnostics & AI
Posted 14th February 2018 by Jane Williams
It was a pleasure to welcome back Miro Venturi to the Global Precision & Biomarkers Leaders Summit, our keynote speaker who spoke on the future of personalised medicine and the interplay of diseases, information and technologies. After his presentation, we sat down with him to get more of an insight into his thoughts on the future.
Honey Reddi on Liquid Biopsies and her Predictions for Precision Medicine
Posted 29th December 2017 by Jane Williams
Honey Reddi, Clinical Laboratory Director at the Jackson Laboratory spoke at the 4th Global Precision Medicine and Biomarkers Leader Summit. She gives us an insight on liquid biopsies in the clinic and the effectiveness of current treatment.
The Best of Digital Pathology in 2017
Posted 11th December 2017 by Jane Williams
It is that time of the year to celebrate the most significant breakthroughs and accomplishments in the field of digital pathology. 2017 has been an exciting year with Philips receiving FDA approval to market their IntelliSite Pathology Solution for primary diagnostic use in the US.
Cancer Therapy in the Genomic Era: Barriers and Distractions
Posted 20th November 2017 by Jane Williams
Recent step change advances in sequencing technologies have delivered a near-complete lexicon of genomic cancer drivers. In parallel, progress in synthetic chemistry has facilitated the assembly of a broad armamentarium of molecularly-targeted therapies. However, whilst immunotherapy agents have produced notable benefits for subgroups of patients, the impact of molecularly-targeted therapies have been relatively modest.
Further unlocking the undeniable power of genomics in cancer will involve both the systematic removal of barriers and the avoidance of distractions that obscure progress. Both of which are discussed here.
Presentation Slide Release: Strategies and Technologies to Deliver Precision Medicine
Posted 25th October 2017 by Jane Williams
Presented at the 4th Global Precision Medicine & Biomarkers Leader Summit, these slides are now available to download and share with your colleagues.
Digital pathology and Artificial Intelligence in the precision medicine era
Posted 15th September 2017 by Jane Williams
In 2017, technological advances in cloud computing and artificial intelligence has pathology positioned to become one of the most talked about medical fields in healthcare.
Considerations for the development of a liquid biopsy assay for cancer
Posted 11th September 2017 by Jane Williams
Non-invasive evaluation of molecular markers has shifted from the realm of prenatal diagnosis to tracking the effect of cancer treatment and management.